Abstract
With the aim to prepare nonpeptidic thrombin inhibitors, the amino acids of the thrombin-inhibiting tripeptide chain D-Phe-Pro-Arg were replaced with isosteres. Arg was replaced with the more rigid P1 truncated p-amidinobenzylamine (Pab), Pro with either cyclopentane-1, 2-dicarboxylic acid or cyclopentene-1,5-dicarboxylic acid, and D-Phe with a series of readily available lipophilic amines. One of the most potent compounds (25, pIC(50) = 6.01) in these series was cocrystallized with thrombin where the X-ray crystal structure provide insight to the structure-activity relationship (SAR).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anticoagulants / chemical synthesis*
-
Anticoagulants / chemistry
-
Anticoagulants / pharmacology
-
Blood Coagulation / drug effects
-
Crystallography, X-Ray
-
Cyclopentanes / chemistry*
-
Cyclopentanes / pharmacology
-
Humans
-
In Vitro Techniques
-
Indicators and Reagents
-
Magnetic Resonance Spectroscopy
-
Models, Molecular
-
Proline / pharmacology*
-
Protein Binding
-
Protein Conformation
-
Stereoisomerism
-
Structure-Activity Relationship
-
Templates, Genetic
-
Thrombin / antagonists & inhibitors*
-
Thrombin / chemistry
Substances
-
Anticoagulants
-
Cyclopentanes
-
Indicators and Reagents
-
cyclopentenedicarboxylic acid
-
Proline
-
Thrombin